You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

673 Results
Drug
Other Name(s): Nolvadex®-D
May 2022
Drug
Feb 2024
Drug
Other Name(s): Matulane®
Dec 2019
Drug
Other Name(s): Lanvis®
Jun 2019
Drug
Other Name(s): Hycamtin®
Apr 2023
Drug
Other Name(s): Torisel ®
Jun 2024
Drug
Other Name(s): Perjeta®
Sep 2022
Drug
Other Name(s): Iclusig®
Aug 2023
Drug
Other Name(s): Ibrance™
May 2021
Regimen
Cancer Type:
Genitourinary, 
Renal cell / Kidney
Intent: Palliative
Funding:
New Drug Funding Program
    Temsirolimus - Metastatic Renal Cell Carcinoma
Jun 2024
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    temozolomide
Jun 2021
Regimen
Cancer Type:
Central Nervous System
Intent: Adjuvant, Curative, Palliative
Funding:
ODB - General Benefit
    procarbazine
ODB - General Benefit
    lomustine
Jan 2023

Pages